WUXIF (Wuxi AppTec Co) Long-Term Debt: $264 Mil (As of Mar. 2026)


WUXIF Wuxi AppTec Co Ltd WUXIF
81 GF Score
Price $21.12
GF Value $12.28
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Wuxi AppTec Co Long-Term Debt?

Wuxi AppTec Co WUXIF -0.33% 81 Long-Term Debt is $264 Mil as of Mar. 2026. GuruFocus rates WUXIF with a GF Score™ of 81/100 and a GF Value™ of $12.28 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Wuxi AppTec Co's Long-Term Debt for the quarter that ended in Mar. 2026 was $264 Mil.

Wuxi AppTec Co's quarterly Long-Term Debt increased from Sep. 2025 ($253 Mil) to Dec. 2025 ($258 Mil) and increased from Dec. 2025 ($258 Mil) to Mar. 2026 ($264 Mil).

Wuxi AppTec Co's annual Long-Term Debt increased from Dec. 2023 ($96 Mil) to Dec. 2024 ($406 Mil) but then declined from Dec. 2024 ($406 Mil) to Dec. 2025 ($258 Mil).

Wuxi AppTec Co  (OTCPK:WUXIF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Wuxi AppTec Co Long-Term Debt Related Terms

Wuxi AppTec Co Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Wuxi AppTec Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wuxi AppTec Co Long-Term Debt Chart

Wuxi AppTec Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 95.32 112.04 96.22 406.49 258.28

Wuxi AppTec Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 105.29 126.02 252.56 258.28 263.90
WUXIF
81GF Score
Wuxi AppTec Co Ltd WUXIF
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $264 Mil mean?
Wuxi AppTec Co (WUXIF) has a Long-Term Debt of $264 Mil as of Mar. 2026.
Is Wuxi AppTec Co's Long-Term Debt too high?
Wuxi AppTec Co's current Long-Term Debt is $264 Mil. Overall, Wuxi AppTec Co has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Wuxi AppTec Co's Long-Term Debt compare to TMO and DHR?
Wuxi AppTec Co's Long-Term Debt of $264 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Diagnostics & Research company?
A good Long-Term Debt depends on the Medical Diagnostics & Research industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Wuxi AppTec Co's current Long-Term Debt is $264 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wuxi AppTec Co stock overvalued right now?
Based on GuruFocus' analysis, Wuxi AppTec Co (WUXIF) is currently considered Significantly Overvalued. The stock's GF Value™ is $12.28, compared to a current price of $21.12 — trading 72% above its estimated fair value. The current Long-Term Debt is $264 Mil. Wuxi AppTec Co's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Wuxi AppTec Co (WUXIF), the current Long-Term Debt is $264 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Wuxi AppTec Co (WUXIF) Overvalued in 2026?

Based on GuruFocus' analysis, Wuxi AppTec Co stock appears to be overvalued. The current stock price of $21.12 is trading 72% above its estimated GF Value™ of $12.28. GuruFocus considers Wuxi AppTec Co to be Significantly Overvalued.

Key valuation signals for WUXIF:

  • Long-Term Debt: $264 Mil
  • GF Value™: $12.28 vs. price of $21.12 (72% above fair value)
  • GF Score™: 81/100 with 4 warning signs

No single metric tells the full story. See the WUXIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Wuxi AppTec Co Business Description

Address 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Pudong New Area, Shanghai, CHN, 200131
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consulting services for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by PRC, Europe, and other regions.
81GF Score

Get the complete analysis for WUXIF

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.12
Price
$12.28
GF Value